Investing in the growth of the retail health segment continues to be a hit-or-miss proposition for major chains around the country. While Walmart is hoping it won’t strike out with its third iteration of a clinic offering, Safeway is pulling the plug on plans to offer “upscale” clinical services—the keystone of which would have been a vendor’s blood analyzer—in 800 stores. Safeway spent around $350 million to build the clinics, hoping the blood tests produced …
Read More